Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461394/
http://dx.doi.org/10.1007/s40278-021-02720-0
_version_ 1784571971849158656
collection PubMed
description
format Online
Article
Text
id pubmed-8461394
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84613942021-09-24 Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports Reactions Weekly Case Report Springer International Publishing 2021-09-25 2021 /pmc/articles/PMC8461394/ http://dx.doi.org/10.1007/s40278-021-02720-0 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports
title Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports
title_full Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports
title_fullStr Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports
title_full_unstemmed Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports
title_short Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports
title_sort bortezomib/ciprofloxacin/tocilizumab: various toxicities and lack of efficacy with an off label treatment: 2 case reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461394/
http://dx.doi.org/10.1007/s40278-021-02720-0

Ejemplares similares